Generative AI may help people breathe better

When Insilico Medicine was founded nearly 10 years ago, AI technology was in its very early stages. But, Insilico’s founder saw AI as a revolutionary method to advance drug discovery—and do so without having to resort to animal testing. Today, that gamble on AI is saving the company substantial time and money throughout the entire process. Using Nvidia’s GPUs, Insilico is now entering Phase II clinical trials with a drug candidate for a relatively rare respiratory disease that was discovered using generative AI. I want a new drug One that won’t make me sick… So go the lyrics of the